SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?
PRCT 30.64-0.4%10:56 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Douglas who wrote (69)4/4/1997 11:47:00 AM
From: Gerald Thomas   of 455
 
I saw that about Pallai leaving a few weeks ago - thought it was a turning point of some kind but wasn't sure what kind...

As far as the other stuff (and I don't mean this in a nasty way)
there is a huge credibility gap when they talk about timetables..
their systemic trial was to be completed in 4th quarter of 1996
and the first news was the sec document three months late not even explaining the results.
It's fine that they made a determination to go with the topical trial
but I think every thinking investor would like to know the results of
pro-2000 when tested in humans...that would say a lot as to what
the results would possibly be in the topical trial...not to mention putting about 10-15$ on the stock price (if somewhat positive).

And think about it -what would they have to lose by saying
that while positive results occured because of competition or cash problems they opted to go with the topical trial...
leaving it hanging like this with no explanation is why the stock is selling for .75. It is possibly management at it's worst or worse yet
maybe there was a problem with pro-2000 either way they have
to explain or the stock goes nowhere.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext